Manchester Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-540	Closed	-$9.33K	–	1443
2025 Q3	$9.33K	Hold	540	–	–	﹤0.01%	879
2025 Q2	$5.07K	Hold	540	–	–	﹤0.01%	902
2025 Q1	$3.84K	Hold	540	–	–	﹤0.01%	934
2024 Q4	$6.3K	Hold	540	–	–	﹤0.01%	865
2024 Q3	$11.1K	Hold	540	–	–	﹤0.01%	776
2024 Q2	$12.1K	Buy	+540	New	+$12.9K	﹤0.01%	729
2023 Q4	–	Sell	-2,000	Closed	-$63.2K	–	1053
2023 Q3	$63.2K	Hold	2,000	–	–	0.01%	391
2023 Q2	$81.6K	Hold	2,000	–	–	0.01%	370
2023 Q1	$74.5K	Hold	2,000	–	–	0.01%	383
2022 Q4	$69.8K	Hold	2,000	–	–	0.01%	355
2022 Q3	$112K	Hold	2,000	–	–	0.02%	272
2022 Q2	$104K	Hold	2,000	–	–	0.02%	296
2022 Q1	$145K	Sell	2,000 -104	-5%	-$8.81K	0.02%	286
2021 Q4	$249K	Hold	2,104	–	–	0.03%	239
2021 Q3	$282K	Buy	+2,104	New	+$319K	0.04%	242